Viewing Study NCT04042051

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-01-03 @ 4:28 AM
Study NCT ID: NCT04042051
Status: TERMINATED
Last Update Posted: 2025-07-22
First Post: 2019-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Copanlisib in Combination With T-DM1 in Pretreated Unresectable Locally Advanced or Metastatic HER2-positive Breast Cancer
Sponsor: Cancer Trials Ireland
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HER2-positive Breast Cancer View
None Metastatic Breast Cancer View
None Locally Advanced Breast Cancer View
None Unresectable Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2 View
None HER2-positive View
None Metastatic View
None Breast View
None Cancer View